Three Was A Crowd At Icos

When Seattle biotech startup Icos raised an eye-popping $69 million last year, it based its sales pitch largely on the credentials of its three top scientists. But could the trio--Amgen founder George Rathman, Genetic Systems founder Robert Nowinski, and Immunex co-founder Christopher Henney--work together? A terse press release from the year-old company on Sept. 27 suggests they couldn't. Nowinski has resigned to pursue "other opportunities," turning the CEO spot over to Rathman.